Questcor Pharmaceuticals Company Profile (NASDAQ:QCOR)

Analyst Ratings

Consensus Ratings for Questcor Pharmaceuticals (NASDAQ:QCOR) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Questcor Pharmaceuticals (NASDAQ:QCOR)
Show:
DateFirmActionRatingPrice TargetActions
7/25/2014Oppenheimer Holdings Inc.DowngradeOutperform -> Market Perform$86.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/24/2014 forward)

Earnings

Earnings History for Questcor Pharmaceuticals (NASDAQ:QCOR)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/24/2014Q214$1.74$1.85$261.02 million$278.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2014Q114$1.61$1.40$239.81 million$227.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2014Q413$1.66$1.67$244.15 million$243.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013Q313$1.29$1.52$199.70 million$236.35 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2013Q2 2013$0.96$1.12$168.96 million$184.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2013Q1 2013$0.96$0.76$157.68 million$135.13 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2013Q4 2012$0.90$1.03$142.58 million$160.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2012$0.74$0.91ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2012$0.63$0.65ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/22/2012$0.41$0.47ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2011$0.26$0.37ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2011$0.17$0.20ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2011$0.15$0.12ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Questcor Pharmaceuticals (NASDAQ:QCOR)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Questcor Pharmaceuticals (NASDAQ:QCOR)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
4/7/2014quarterly$0.306/27/20147/1/20147/8/2014Tweet This Announcement  Share This Announcement on StockTwits
2/14/2014quarterly$0.301.58%4/15/20144/18/20144/25/2014Tweet This Announcement  Share This Announcement on StockTwits
12/11/2013quarterly$0.302.31%1/15/20141/17/20141/24/2014Tweet This Announcement  Share This Announcement on StockTwits
10/10/2013quarterly$0.302.01%10/18/201310/22/201310/30/2013Tweet This Announcement  Share This Announcement on StockTwits
5/29/2013quarterly$0.252.92%7/18/20137/22/20137/30/2013Tweet This Announcement  Share This Announcement on StockTwits
2/26/2013quarterly$0.253.03%4/18/20134/22/20134/30/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Questcor Pharmaceuticals (NASDAQ:QCOR)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
8/13/2014Don M BaileyInsiderSell40,000$91.96$3,678,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2014Michael H MulroyInsiderSell10,000$92.33$923,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/14/2014Don M BaileyInsiderSell40,000$95.54$3,821,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2014Michael H MulroyInsiderSell10,000$90.89$908,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/24/2014David YoungInsiderSell6,000$91.96$551,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/13/2014Don M BaileyCEOSell40,000$89.83$3,593,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2014Michael H MulroyInsiderSell10,000$88.57$885,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2014David Jeffrey MedeirosEVPSell2,292$89.66$205,500.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2014Don BaileyCEOSell40,000$87.05$3,482,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2014Michael MulroyInsiderSell10,000$87.99$879,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/21/2014David Jeffrey MedeirosEVPSell2,292$77.15$176,827.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2014Don BaileyCEOSell40,000$79.65$3,186,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/10/2014Michael MulroyInsiderSell10,000$85.04$850,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/7/2014Stephen FarrellDirectorSell10,000$81.43$814,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2014David Jeffrey MedeirosEVPSell2,291$62.61$143,439.51View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2014David YoungInsiderSell6,000$62.28$373,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2014Don BaileyCEOSell40,000$62.71$2,508,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2014Michael MulroyInsiderSell10,000$64.80$648,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2014Broadwood Partners LpDirectorSell83,600$79.59$6,653,724.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Broadwood Partners LpDirectorSell306,400$74.94$22,961,616.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2014Broadwood Partners LpDirectorSell85,000$69.10$5,873,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/30/2014Broadwood Partners LpDirectorSell50,000$66.55$3,327,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/24/2014David YoungInsiderSell6,000$64.38$386,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/23/2014Broadwood Partners LpDirectorSell20,000$65.00$1,300,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/23/2014David Jeffrey MedeirosEVPSell133,541$64.91$8,668,146.31View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2014David Jeffrey MedeirosEVPSell50,000$62.00$3,100,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/13/2014Don BaileyCEOSell40,000$53.64$2,145,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2013Neal BradsherDirectorSell40,000$62.41$2,496,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2013Broadwood Partners LpDirectorSell500,000$62.37$31,185,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/14/2013Don BaileyCEOSell40,000$62.16$2,486,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/14/2013Virgil ThompsonDirectorSell2,500$60.50$151,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013Virgil ThompsonDirectorSell5,000$63.75$318,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2013Don BaileyCEOSell40,000$63.69$2,547,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013David Jeffrey MedeirosEVPSell55,000$73.98$4,068,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2013Virgil ThompsonDirectorSell5,000$69.12$345,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2013David Jeffrey MedeirosEVPSell110,597$67.85$7,504,006.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/6/2013David Jeffrey MedeirosEVPSell58,831$66.69$3,923,439.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2013Don M BaileyCEOSell33,339$49.31$1,643,946.09View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2013Virgil D ThompsonDirectorSell5,000$49.29$246,450.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/14/2013Virgil D ThompsonDirectorSell5,000$45.55$227,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/13/2013Don M BaileyCEOSell40,000$45.01$1,800,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013Don M BaileyCEOSell180,000$40.14$7,225,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013Virgil D ThompsonDirectorSell5,000$37.46$187,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/9/2013Virgil D ThompsonDirectorSell2,187$35.00$76,545.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/21/2013Virgil D ThompsonDirectorSell47,500$35.00$1,662,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2012David Jeffrey MedeirosEVPBuy55,000$23.92$1,315,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2012Stephen Lahue CarttVPBuy10,000$24.17$241,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2012Mitchell J Md BluttDirectorSell24,730$47.60$1,177,148.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Questcor Pharmaceuticals (NASDAQ:QCOR)
DateHeadline
01/16/16 02:55 PMAetna Member Services Phone Numbers & Customer Service Helpline Support - The Voice Observer (blog) - Aetna Member Services Phone Numbers & Customer Service Helpline SupportThe Voice Observer (blog)Aetna, Inc. is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans.and more »
06/17/15 05:46 PMMallinckrodt’s Questcor Said Facing Multistate Antitrust Probe -
05/05/15 12:30 PMMallinckrodt Tops Q2 Earnings & Revenues on Acquisitions - Analyst Blog -
10/14/14 09:07 AMMallinckrodt shares rise on earnings outlook -
07/24/14 08:28 AMMS drug sales drive Questcor profit -
07/15/14 08:29 AMUpdate-Moody's assigns Ba2 to Mallinckrodt's new sr. secured term loan -

Social

About Questcor Pharmaceuticals

Questcor Pharmaceuticals logoQuestcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. The Company is focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Its primary product is H.P. Acthar Gel (repository corticotropin injection), or Acthar, an injectable drug that is approved by the United States food and drug administration (FDA), for the treatment of 19 indications. Its research and development program is focused on: the evaluation of the use of Acthar for certain on-label indications; the investigation of other potential uses of Acthar for indications not FDA approved; and the expansion of its understanding of how Acthar works in the human body (pharmacology), and ultimately, its mechanisms of action in the disease states for which it is used, or may be used in the future. The Company sells Doral to pharmaceutical wholesalers, which resell Doral primarily to retail pharmacies and hospitals.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Pharmaceuticals
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: QCOR
  • CUSIP: 74835Y10
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $0
  • 200 Day Moving Average: $0
  • P/E Ratio: N/A
  • P/E Growth: 0
  • Market Cap: $N/A
  • Current Year EPS Consensus Estimate: $6.73 EPS
  • Next Year EPS Consensus Estimate: $7.35 EPS
Additional Links:
Questcor Pharmaceuticals (NASDAQ:QCOR) Chart for Sunday, July, 24, 2016